From Self-sufficiency
Jump to: navigation, search
File:Griseofulvin 3D.png
Systematic (IUPAC) name
(2S,6'R)- 7-chloro- 2',4,6-trimethoxy- 6'-methyl- 3H,4'H-spiro [1-benzofuran- 2,1'-cyclohex[2]ene]- 3,4'-dione
Clinical data
Routes of
Legal status
Legal status
  • POM (UK), ℞-only (U.S.)
Pharmacokinetic data
Bioavailability Highly variable (25 to 70%)
Metabolism Hepatic demethylation and glucuronidation
Biological half-life 9-21 hours
CAS Number 126-07-8
ATC code D01AA08 (WHO) D01BA01
PubChem CID 441140
DrugBank APRD01004
ChemSpider 389934
Chemical data
Formula C17H17ClO6
Molar mass 352.766 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Griseofulvin (also known as Grisovin, a proprietary name of Glaxo Laboratories) is an antifungal drug that is administered orally. It is used both in animals and in humans, to treat fungal infections of the skin (commonly known as ringworm) and nails. It is derived from the mold Penicillium griseofulvum.


The drug binds to tubulin, interfering with microtubule function, thus inhibiting mitosis.

It binds to keratin in keratin precursor cells and makes them resistant to fungal infections. It is only when hair or skin is replaced by the keratin-griseofulvin complex that the drug reaches its site of action. Griseofulvin will then enter the dermatophyte through energy dependent transport processes and bind to fungal microtubules. This alters the processing for mitosis and also underlying information for deposition of fungal cell walls.

Treatment of fungal infections

Griseofulvin is used to treat the following fungal infections:
Tinea capitis (ringworm of the scalp)
Tinea corporis (ringworm of the body)
Tinea pedis (athlete's foot)
Tinea unguium (onychomycosis)
Tinea cruris (ringworm of the thigh)
Tinea barbae (barber's itch)
Tinea versicolor (Pityriasis, Fungus of the Sun)

Potential for cancer treatment

When cancer cells divide (undergo mitosis), they use an unusual mechanism to ensure the correct genetic material is present within each of the resulting tumor cells. Laboratory experiments at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) show that griseofulvin causes cancer cells to fail to divide the chromosomes correctly, which eventually leads to tumor cell death. Griseofulvin does not interfere with cell division in healthy cells. The observed effect is not strong, but is significant. Griseofulvin may be combined with other treatments to improve its effectiveness and may lead to the development of more effective future drug treatments with very low toxic side effects[1].

Side effects

Known side effects of griseofulvin include:

  • Can reduce the effectiveness of oral contraceptives as it a cytochrome p450 enzyme inducer
  • Confusion
  • Considered unsafe for those with porphyria
  • Diarrhea
  • Dizziness
  • Fatigue
  • Headache
  • Hives
  • Impairment of performance of routine activities
  • Impairment of liver enzymatic activity
  • Inability to fall or stay asleep
  • Itching
  • Loss of taste sensation
  • Nausea
  • Oral thrush (yeast infection of the mouth)
  • Possibly a teratogen inducing mutations
  • Sensitivity to alcohol, with a disulfiram/antabuse-like reaction
  • Sensitivity to prolonged sun exposure
  • Skin rashes
  • Swelling
  • Tingling in the hands or feet
  • Upper abdominal pain
  • Vomiting

Common brand names

  • Grifulvin V
  • Gris-PEG
  • S-Fulvin


See also

Medicinal mushrooms


  1. [1]

External links


de:Griseofulvin es:Griseofulvina fa:گریزئوفولوین it:Griseofulvina hu:Grizeofulvin ja:グリセオフルビン pl:Gryzeofulwina pt:Griseofulvina